Both in Biotechnology
Surrozen vs C4 Therapeutics
Over the past year SRZN returned +117.3% and CCCC returned +29.6%; their daily moves had a correlation of 0.20.
SRZN +117.3% CCCC +29.6%Growth of $1, one year, split-adjusted
| Metric | SRZN | CCCC |
|---|---|---|
| Price | $30.27 | $3.44 |
| Market cap | $355.8M | $422.6M |
| Today | +2.51% | +7.01% |
| 1 month | −5.3% | +9.7% |
| 6 months | −4.1% | +34.2% |
| Year to date | +33.9% | +79.8% |
| 1 year | +117.3% | +29.6% |
| Revenue growth (YoY) | +408.6% | +2.8% |
| Gross margin | 100.0% | 100.0% |
| Net margin | 640.8% | −355.9% |
| P/E (TTM) | — | — |
| Price / sales | 30.9× | 12.1× |
| Net cash | $102.0M | $253.7M |
| Dividend yield | — | — |
| Volatility (60d) | 173.8% | 65.2% |
| Short % of float | 37.0% | 43.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).